Sh Fosun Pharma reported CNY9.81B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Jiangsu Hengrui CNY 8.44B 1.01B Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Sh Pharmaceutical CNY 73.48B 2.65B Sep/2025
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Wuxi Apptec CNY 12.6B 88.06M Dec/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025